check my post history, plenty of analysis there. Theres nothing fundamentally changing that warrants new analysis besides the fact that Daybue is coming up short with respect to market expectations of sales.
I’ve commented saying the 2591 results are good to the point it’ll most likely get approved in the future. Theres nothing much else happening for NEU besides waiting for 2591 to mature in development and for jurisdictional approvals for Daybue.
I steer clear of this forum in the most part now because most of it is “I think it’ll get bought out for $Xbn in the future” or “the high end of town is against us and controlling the share price and that’s why it’s down”
- Forums
- ASX - By Stock
- NEU
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.12%
!
$12.40

Ann: Trofinetide marketing application submitted in Europe, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.40 |
Change
-0.140(1.12%) |
Mkt cap ! $1.553B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.34 | $2.793M | 223.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 139 | $12.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.40 | 55 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5 | 12.360 |
8 | 1173 | 12.350 |
6 | 1668 | 12.340 |
5 | 1572 | 12.330 |
4 | 1304 | 12.320 |
Price($) | Vol. | No. |
---|---|---|
12.380 | 1258 | 12 |
12.390 | 1067 | 9 |
12.400 | 1509 | 7 |
12.410 | 1953 | 10 |
12.420 | 1357 | 5 |
Last trade - 12.27pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |